-
Independent development of lymphoid and histiocytic malignancies from a shared early precursor
Study
EGAS00001001353
-
Cell fate mapping of human glioblastoma reveals an invariant stem cell hierarchy pre- and post-treatment
Study
EGAS00001002424
-
The evolutionary trajectory of a highly recurrent paediatric high grade neuroepithelial tumour with MN1:BEND2 fusion
Study
EGAS00001002432
-
Exome Sequencing to Define the Landscape of Plasma Cells in Systemic Light chain Amyloidosis
Study
EGAS00001001418
-
Integrative genomic and transcriptomic analysis of adult leiomyosarcoma (HIPO-028, HIPO-018, HIPO-021)
Study
EGAS00001002437
-
Successful immune checkpoint blockade in a patient with advanced stage microsatellite unstable biliary tract cancer (H021)
Study
EGAS00001002441
-
Whole genome sequencing of metastatic melanomas from a patient with primary resistance to BRAF inhibition
Study
EGAS00001000580
-
RNAseq of preneoplasia lung adenocarcinoma
Study
EGAS50000000271
-
Clonal_expansion_of_mutated_cell_population_in_bladder_urothelium_
Study
EGAS00001001687
-
Successful BRAF/MEK-inhibition in a young patient with BRAF V600E-mutated extrapancreatic acinar cell carcinoma (HIPO-021)
Study
EGAS00001004282
-
Melanoma_C32_ENU_Resistance_to_Single_Agent_Therapy
Study
EGAS00001001697
-
Myeloma_Follow_up_Pilot
Study
EGAS00001000743
-
Linking genes, genomic instability and molecular subgroups in medulloblastoma
Study
EGAS00001000085
-
Integrated Single-Nucleus and Spatial Transcriptomics Elucidate Heterogeneity and Hypoxia-Driven Organization of Supratentorial Ependymoma
Study
EGAS50000001318
-
H3K27ac and RNA-seq data of neuroblastoma PDXs and/or primary tumors
Study
EGAS00001002505
-
Changes in AXL and/or MITF melanoma subpopulations in patients receiving immunotherapy
Study
EGAS50000001080
-
ERBB2/HER2 alterations in ctDNA and metachronous tissues of patients with metastatic urothelial cancer - WGS
Study
EGAS50000001082
-
ERBB2/HER2 alterations in ctDNA and metachronous tissues of patients with metastatic urothelial cancer - Targeted
Study
EGAS50000001081
-
Somatic_Variation_Angiosarcoma
Study
EGAS00001002610
-
Genome-wide genetic and epigenetic dataset of pancreatic acinar cell carcinomas
Study
EGAS00001002533
-
Capture Hi-C on MM
Study
EGAS00001002614
-
Copy-number signatures and mutational processes in ovarian carcinoma
Study
EGAS00001002557
-
Exome-wide somatic mutation characterization of small bowel adenocarcinoma
Study
EGAS00001002559
-
Whole genome sequencing of preneoplasia lung adenocarcinoma
Study
EGAS50000000272
-
Integrated genetic and epigenetic analysis of myxofibrosarcoma
Study
EGAS00001002889
-
Gene expression analysis of clear cell renal cell carcinoma
Study
EGAS50000001324
-
3D chromatin analysis of clear cell renal cell carcinoma using micro-C
Study
EGAS50000001323
-
ChIP-seq analysis of clear cell renal cell carcinoma
Study
EGAS50000001322
-
Comparative genomics research for Chinese colorectal cancer
Study
EGAS00001002576
-
Roma Sequencing Study
Study
EGAS00001004287
-
DEPArray-based sorting of pure carcinoma and stromal populations from formalin-fixed paraffin-embedded (FFPE) tissues followed by targeted sequencing
Study
EGAS50000001327
-
DEPArray-based sorting of pure carcinoma and stromal populations from formalin-fixed paraffin-embedded (FFPE) tissues followed by shallow whole genome sequencing
Study
EGAS50000001328
-
Inhibiton of the GABPB1L-containing GABP tetramer is sufficient to reverse replicative immortality in TERT promoter mutant glioblastoma cells.
Study
EGAS00001002582
-
Identification of New Therapeutic Targets for Renal Medullary Carcinoma via Integrated Genomic and Transcriptomic Profiling
Study
EGAS50000001280
-
Systematic kinase inhibitor profiling identifies CDK9 as a synthetic lethal target in NUT midline carcinoma
Study
EGAS00001002588
-
The exomic landscape of t(14,18) negative diffuse follicular lymphoma with 1p36 deletion
Study
EGAS00001002594
-
Whole Genomes Define Concordance in Matched Primary, Xenograft, and Organoid Models of Pancreas Cancer
Study
EGAS00001002597
-
OAC scRNASeq
Study
EGAS00001006469
-
Genetic and Functional Drivers of Diffuse Large B Cell Lymphoma
Study
EGAS00001002606
-
The genomic landscape of cutaneous squamous cell carcinoma from immunosuppressed and immunocompetent patients reveals common drivers and a novel mutational signature associated with chronic azathioprine exposure
Study
EGAS00001002612
-
The_Transcriptome_of_PLX4032_resistance
Study
EGAS00001000413
-
Primary_angiosarcoma_Whole_Genome_Sequencing
Study
EGAS00001000851
-
Identification of a Fumarate-Hydratase Deficient-like RCC Subtype with Convergent Pathway Alterations
Study
EGAS00001002646
-
Detection of clinically relevant genetic and transcriptomic landscape in DLBCL uniformly treated by R-CHOP
Study
EGAS00001002657
-
Discovery_of_resistance_mechanisms_to_the_BRAF_inhibitor_vemurafenib_in_metastatic_BRAF_mutant_melanoma
Study
EGAS00001000812
-
WGS of 32 paired SRCC samples
Study
EGAS00001002668
-
Identification_of_drug_resistance_genes_in_melanoma_by_mRNA_gene_expression
Study
EGAS00001000815
-
Identification_of_drug_resistance_genes_in_melanoma_by_small_RNAs_expression_analysis
Study
EGAS00001000816
-
Therapeutic Targeting of Ependymoma as Informed by Oncogenic Enhancer Profiling
Study
EGAS00001002696
-
Whole exome sequencing of cell-free DNA reveals temporo-spatial heterogeneity and identifies treatment-resistant clones in neuroblastoma
Study
EGAS00001002705